| Code | 9924E | ||||||||||
| MA number | 16/0132/25-S | ||||||||||
| Product Form: | tbl flm 14x50 mg (blis.OPA/Al/PVC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.05.2025 |
| Validity: | 21.05.2030 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Eltrombopag Teva 50 mg_tbl flm_05/2025_REG.pdf
|
| PIL: |
PIL_Eltrombopag Teva 50 mg_tbl flm_05/2025_REG.pdf
|
| Safety feature | Yes |
| Data update: | 26.05.2025 |
